Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | FAAH | O00519 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | MAOA | P21397 | 6/20 | 0.36 |
| ▸ | MAOB | P27338 | 6/20 | 0.36 |
| ▸ | KDM1A | O60341 | 4/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.36 |
| ▸ | CYP2B6 | P20813 | 3/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | HTR1A | P08908 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4017099 | 0.98 | KDM4E (0.43) | KDM4ENPC1RAB9AFAAHRECQL | |
| SCHEMBL3096069 | 0.95 | KDM4E (0.44) | KDM4ENPC1RAB9AFAAHRECQL | |
| SCHEMBL6434620 | 0.93 | TSHR (0.43) | KDM4ENPC1RAB9AFAAHRECQL | |
| SCHEMBL3078602 | 0.90 | KDM4E (0.52) | KDM4ENPC1RAB9ATSHRMAOA | |
| SCHEMBL7632848 | 0.87 | TSHR (0.44) | KDM4ENPC1RAB9AFAAHTSHR | |
| SCHEMBL11612135 | 0.87 | KDM1A (0.44) | KDM4ENPC1RAB9AFAAHTSHR | |
| SCHEMBL16263640 | 0.83 | NPC1 (0.47) | KDM4ENPC1RAB9ATSHRMAOA | |
| SCHEMBL9778853 | 0.82 | KDM1A (0.49) | KDM4ENPC1RAB9ATSHRMAOA | |
| SCHEMBL16263580 | 0.81 | KDM4E (0.42) | KDM4ENPC1RAB9ATSHRMAOA | |
| SCHEMBL9778797 | 0.78 | MAOB (0.47) | KDM4ERAB9ARECQLMAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 489 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118538999-A | Electrolyte additive, electrolyte containing additive and battery | 东南大学 | 2024-08-23 | — | — | CN | claimed |
| CN-113707933-B | Preparation method of solid electrolyte nano dispersion liquid of lithium ion battery and solid electrolyte nano dispersion liquid | 浙江蓝珧新材料科技有限公司 | 2024-04-09 | — | — | CN | claimed |
| US-11814563-B2 | Bioreachable chiral dopants for liquid crystal applications | ZYMERGEN INC. (US) | 2023-11-14 | — | — | US | claimed |
| US-20230203378-A1 | FORMULATIONS OF BIOREACHABLE DOPANTS FOR LIQUID CRYSTALS | KENT STATE UNIVERSITY | 2023-06-29 | — | — | US | claimed |
| US-20220025267-A1 | BIOREACHABLE CHIRAL DOPANTS FOR LIQUID CRYSTAL APPLICATIONS | ZYMERGEN ACQUISITION SUB, INC. | 2022-01-27 | — | — | US | claimed |
| CN-113707933-A | Preparation method of solid electrolyte nano dispersion liquid of lithium ion battery and solid electrolyte nano dispersion liquid | 北京卫蓝新能源科技有限公司 | 2021-11-26 | — | — | CN | claimed |
| EP-3891252-A2 | BIOREACHABLE CHIRAL DOPANTS FOR LIQUID CRYSTAL APPLICATIONS | Zymergen Inc. (US) | 2021-10-13 | — | — | EP | claimed |
| CN-113454187-A | Biologically available chiral dopants for liquid crystal applications | 齐默尔根公司 | 2021-09-28 | — | — | CN | claimed |
| CN-108794537-B | Preparation method of sulfur poisoning resistant platinum complex | 广东工业大学 | 2020-10-23 | — | — | CN | claimed |
| CN-103102436-B | Liquid polymers and the synthesis of functionalized polymeric | 株式会社普利司通 | 2016-08-03 | — | — | CN | claimed |
| WO-2009032154-A2 | SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER | BRIDGESTONE CORPORATION (JP) | 2009-03-12 | — | — | WO | claimed |
| US-20090062451-A1 | SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER | BRIDGESTONE CORPORATION (JP) | 2009-03-05 | — | — | US | claimed |
| EP-0743574-B1 | Migration imaging members | XEROX CORP (US) | 2000-12-27 | — | — | EP | claimed |
| EP-0743573-B1 | Method for obtaining image contrast migration imaging members | XEROX CORP (US) | 2000-09-06 | — | — | EP | claimed |
| US-6036888-A | ADDING SULFUR-CONTAINING HETEROCYCLIC RING COMPOUNDS TO AQUEOUS ALKANOLAMINE SOLUTION TO INHIBIT CORROSION OF METALS IN ACID GAS RICH AND ACID GAS LEAN PORTIONS OF AN ACID GAS REMOVAL UNIT | BETZDEARBORN INC. (US) | 2000-03-14 | — | — | US | claimed |
| WO-1999010561-A1 | CORROSION INHIBITOR FOR ALKANOLAMINE UNITS | BETZDEARBORN INC. (US) | 1999-03-04 | — | — | WO | claimed |
| EP-0743573-A2 | Method for obtaining image contrast migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| EP-0743574-A2 | Migration imaging members | XEROX CORPORATION (US) | 1996-11-20 | — | — | EP | claimed |
| US-5563014-A | SOFTENABLE LAYER CONTAINIG PHOTOSENSITIVE MARKING MATERIAL; TRANSPARENTIZING AGENT | XEROX CORPORATION (US) | 1996-10-08 | — | — | US | claimed |
| US-5514505-A | SELECTIVE TRANSPARENTIZATION OF PHOTOSENSITIVE MIGRATION MARKING PARTICLES EMBEDDED NEAR THE SURFACE OF A SOFTENABLE LAYER SUPPORTED BY AN ELECTROCONDUCTIVE SUBSTRATE | XEROX CORPORATION (US) | 1996-05-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062451-A1 | SYNTHESIS OF A LIQUID POLYMER AND A FUNCTIONALIZED POLYMER | FGB, FIP1L1, PUF60 | KDM4E 2746/4885NPC1 4800/4885RAB9A 3353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.